TheY speak about US
Versantis is proud to be selected to present at the Investors Summit 2017 as one of the 7 finest startups of Switzerland!
More information and pictures of the event here:
We are proud to announce that Cydan Development, a sponsor of the prestigious MassChallenge accelerator, has awarded one of its five MassChallenge scholarships to Versantis.
The Job Journal introduced Versantis as a model of successful spin-off from ETH Zurich. M Kabbaj and V Forster discuss the challenges and hurdles related to the translation of a pharmaceutical technology from an academic prototype to a marketable product.
We are proud to serve a role model and encourage all entrepreneurs to read the tips we present in the article.
Versantis is a Challenge Finalist of Pioneers Asia.
According to the Pioneers Asia jury, Versantis is addressing a serious problem that has previously been neglected, with a very strong team and expertise.
Universal antidotes: we can do better than burnt toasts!
Vincent Forster (Versantis CEO) presented Versantis' innovative detoxification technology during a TED talk at TEDxHamburg. Flying performance!
Nano-antidotes for drug overdose and poisoning
Vincent Forster and Jean-Christophe Leroux
Science Translational Medicine 7(229):p.290ps14
In this perspective article, we critically review the recent progresses in antidotal medicine which are rising to the challenge of the growing overdose epidemic.
In the US, more than 2.5 million people are subjected to drug overdose which is the most common form of deliberate self-harm and accidental death!
The Gebert Ruef Stiftung is supporting Versantis R&D with CHF 320'000.-. We are honored by this prestigious award which will be instrumental for the translation of VS-01 to the patients' bedside. Thank you!
More info about the Foundation and the project here:
The international Startup press is featuring Versantis and its management team:
" Versantis, using liposomes technology to detoxification"
" We want to save lives from drug overdoses"
Versantis is selected as a deVigier finalist.
Die Leber ist das groesste Organ im Koerper und spielt eine Schluesselrolle bei der Entgiftung von Stoffwechselschlacken. Bei Leberversagen, sammeln sich diese giftigen Abfaelle schnell im Koerper und gefaehrden das Leben von Patienten. Versantis hat eine revolutionaere Dialyseloesung entwickelt, die verschiedene Giftstoffe aus dem Blut effektiv entfernen kann womit die akute Vergiftung schnell behandelt werden kann. Dieser neue Ansatz bietet eine Loesung, um auf die heutigen medizinischen Herausforderungen von wachsenden Patientenzahlen mit Leberversagen zu reagieren.
The clinical value and potential of Versantis' technology has been endorsed by the prestigious Science Translational Medicine. This is a major achievement for the project and a great recognition from the medical community.
**Read the main article or check our the press coverage below**
Versantis was invited to pitch at the CTI-Invest Swiss Venture Day. It was a very productive event with great people to connect with. We received excellent and encouraging feedbacks!
**Check out the teaser of our pitch**
We got the kick! Versantis' co-founders gave a solid presentation that satisfied Venture Kick's Jury. We receive the CHF 20'000.- financial support and are now enrolled in the the final stage.
**Have a look at our interview**